Royal Healthcare in Singapore provides NEC’s “FonesVisuas Test” for Disease Risk Prediction
TOKYO, Mar 26, 2026 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise…

















